Haemorrhagic bullae and purpura associated with the Bruton tyrosine kinase inhibitor ibrutinib. Steele L, George C, Cerio R, O'Toole EA, et al. Clin Exp Dermatol 2022;47:488-490.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Steele L, George C, Cerio R, O'Toole EA, et al. Haemorrhagic bullae and purpura associated with the Bruton tyrosine kinase inhibitor ibrutinib. Clin Exp Dermatol 2022;47:488-490.
PMID: 34882824